Tandem Diabetes Care
TNDM
TNDM
378 hedge funds and large institutions have $6.84B invested in Tandem Diabetes Care in 2022 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 153 increasing their positions, 119 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
378
Holders Change
-9
Holders Change %
-2.33%
% of All Funds
5.98%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
62
Increased
153
Reduced
119
Closed
66
Calls
$55.9M
Puts
$24.9M
Net Calls
+$31M
Net Calls Change
+$2.01M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$57.8M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$56.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$50.8M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$31.5M |
| 5 |
Millennium Management
New York
|
+$28.2M |
Top Sellers
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$117M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$67.6M |
| 3 |
Jennison Associates
New York
|
-$41.8M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$36.3M |
| 5 |
Morgan Stanley
New York
|
-$35.3M |
